Keywords: 180-day, exclusivity, teva, famotidine, pharmaceutical, industries, been

180-day exclusivity for Teva's famotidine

Article | 06 June 2001

Print This

Teva Pharmaceutical Industries has been awarded final approval by the USFood and Drug Administration for its 10mg famotidine tablets for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in